ASN's Mission

To create a world without kidney diseases, the ASN Alliance for Kidney Health elevates care by educating and informing, driving breakthroughs and innovation, and advocating for policies that create transformative changes in kidney medicine throughout the world.

learn more

Contact ASN

1401 H St, NW, Ste 900, Washington, DC 20005

email@asn-online.org

202-640-4660

The Latest on X

Kidney Week

Abstract: TH-PO458

Pre-ESRD Systolic Blood Pressure Trajectory and Post-ESRD Mortality

Session Information

Category: Chronic Kidney Disease (Non-Dialysis)

  • 303 CKD: Epidemiology, Outcomes - Cardiovascular

Authors

  • Sumida, Keiichi, Nephrology Center, Toranomon Hospital Kajigaya, Kawasaki, KANAGAWA, Japan
  • Molnar, Miklos Zsolt, University of Tennessee Health Science Center, Memphis, Tennessee, United States
  • Potukuchi, Praveen Kumar, University of Tennessee Health Science Center, Memphis, Tennessee, United States
  • Thomas, Fridtjof, University of Tennessee Health Science Center, Memphis, Tennessee, United States
  • Gosmanova, Elvira, Stratton VA Medical Center, Albany, New York, United States
  • Sim, John J., Kaiser Permanente Los Angeles Medical Center, Los Angeles, California, United States
  • Yamagata, Kunihiro, University of Tsukuba, Tsukuba, Japan
  • Kalantar-Zadeh, Kamyar, University of California Irvine, School of Medicine, Orange, California, United States
  • Kovesdy, Csaba P., University of Tennessee Health Science Center, Memphis, Tennessee, United States
Background

Pre-ESRD systolic blood pressure (SBP) shows a reverse J-shaped association with post-ESRD mortality. However, the pre-ESRD association of SBP trajectories (decrease vs. increase vs. stable over time) with post-ESRD mortality is unknown.

Methods

We assessed SBP measurements in the last 3 years prior to dialysis in 39,383 US veterans with incident ESRD. SBP slopes and baseline levels were categorized (<-5, -5-<5, and ≥5 mmHg/year for slopes; and <130, 130-<150, and ≥150 mmHg for baseline) and combined into 9 mutually exclusive groups with slope of -5-<5 mmHg/year and baseline of 130-<150 mmHg as referent. Associations with all-cause post-ESRD mortality were examined in multivariable-adjusted Cox models.

Results

The median (interquartile interval) SBP slope and baseline SBP were -0.1 (-2.4-1.9) mmHg/year and 140 (133-149) mmHg. Decrease in SBP was associated with higher mortality, with the highest risk seen with SBP slope of <-5 mmHg/year combined with baseline SBP of <130 mmHg (adjusted hazard ratio [95% CI]: 2.02 [1.70-2.40], vs. referent; Figure). Increase in SBP was associated with lower mortality independent of baseline SBP, as was stable SBP in patients with baseline SBP ≥130 mmHg.

Conclusion

Decrease in SBP prior to dialysis start is associated with higher post-ESRD mortality, especially in patients with lower baseline SBP. Increasing SBP is associated with better outcomes independent of baseline SBP. Further studies are needed to test whether modification of pre-ESRD SBP trajectories can improve clinical outcomes in incident ESRD patients.

Funding

  • NIDDK Support